Clinical Trial

Prostate Reirradiation Toxicity Outcomes Feasibility Study

Study acronym: RO-PIP
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 15, 2022 (before its estimated November 15, 2024 completion). Its status may not reflect the trial's current state.
Summary
The RO-PIP trial aims to determine the feasibility of recruitment to a trial randomising patients to salvage ultra-hypofractionated external beam radiotherapy or high dose rate brachytherapy and provide prospective data on patient recorded toxicity outcomes that will inform a future phase III trial.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-11-05.
Trial Details
NCT Number NCT05614700
Lead Sponsor University of Leeds
Conditions Prostate Cancer, Radiotherapy Side Effect
Enrollment 60 participants
Start Date 2022-11-15
Primary Completion 2024-11-15 (estimated)
Study Completion 2026-11-15 (estimated)
Updated on ClinicalTrials.gov 2022-11-15